Exact Mass: 437.24784239999997
Exact Mass Matches: 437.24784239999997
Found 371 metabolites which its exact mass value is equals to given mass value 437.24784239999997
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
N1,N10-Dicoumaroylspermidine
C25H31N3O4 (437.23144460000003)
N1,N10-Dicoumaroylspermidine is found in fats and oils. N1,N10-Dicoumaroylspermidine is an alkaloid from Helianthus annuus (sunflower) Vicia faba and Pyrus communis (pear). Alkaloid from Helianthus annuus (sunflower) Vicia faba and Pyrus communis (pear). N1,N10-Dicoumaroylspermidine is found in pomes, fats and oils, and pulses.
fMLP;N-Formyl-MLF
C21H31N3O5S (437.19843160000005)
N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.
ORG 20599
C25H40ClNO3 (437.26965600000005)
Disopyramid phosphate
C21H32N3O5P (437.20794720000004)
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
Lagerstroemine
Lagerstroemine is found in fruits. Lagerstroemine is an alkaloid from Plantago psyllium seeds (African plantain
LysoPE(P-16:0/0:0)
C21H44NO6P (437.29060940000005)
1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine is an phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage. While most phospholipids have a saturated fatty acid on C-1 and an unsaturated fatty acid on C-2 of the glycerol backbone, the fatty acid distribution at the C-1 and C-2 positions of glycerol within phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. PEs are neutral zwitterions at physiological pH. They mostly have palmitic or stearic acid on carbon 1 and a long chain unsaturated fatty acid (e.g. 18:2, 20:4 and 22:6) on carbon 2. PE synthesis can occur via two pathways. The first requires that ethanolamine be activated by phosphorylation and then coupled to CDP. The ethanolamine is then transferred from CDP-ethanolamine to phosphatidic acid to yield PE. The second involves the decarboxylation of PS. Plasmalogens are glycerol ether phospholipids. They are of two types, alkyl ether (-O-CH2-) and alkenyl ether (-O-CH=CH-). Dihydroxyacetone phosphate (DHAP) serves as the glycerol precursor for the synthesis of plasmalogens. Three major classes of plasmalogens have been identified: choline, ethanolamine and serine derivatives. Ethanolamine plasmalogen is prevalent in myelin. Choline plasmalogen is abundant in cardiac tissue. Usually, the highest proportion of the plasmalogen form is in the ethanolamine class with rather less in choline, and commonly little or none in other phospholipids such as phosphatidylinositol. In choline plasmalogens of most tissues, a higher proportion is often of the O-alkyl rather than the O-alkenyl form, but the reverse tends to be true in heart lipids. In animal tissues, the alkyl and alkenyl moieties in both non-polar and phospholipids tend to be rather simple in composition with 16:0, 18:0 and 18:1 (double bond in position 9) predominating. Ether analogues of triacylglycerols, i.e. 1-alkyldiacyl-sn-glycerols, are present at trace levels only if at all in most animal tissues, but they can be major components of some marine lipids. 1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine is an phospho-ether lipid. Ether lipids are lipids in which one or more of the carbon atoms on glycerol is bonded to an alkyl chain via an ether linkage, as opposed to the usual ester linkage.
Neoline
Neoline. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=466-26-2 (retrieved 2024-07-24) (CAS RN: 466-26-2). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Neoline,?the active ingredient of processed aconite root (PA), alleviated oxaliplatin-induced peripheral neuropathy in mice. Neoline can be used as a marker compound to determine the quality of the PA products for the treatment of neuropathic pain[1]. Neoline,?the active ingredient of processed aconite root (PA), alleviated oxaliplatin-induced peripheral neuropathy in mice. Neoline can be used as a marker compound to determine the quality of the PA products for the treatment of neuropathic pain[1].
2-Chloro-1-[(2S,3S,5S,10S,13S)-3-hydroxy-10,13-dimethyl-2-morpholino-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
C25H40ClNO3 (437.26965600000005)
Levonantradol
C27H35NO4 (437.25659500000006)
N-Formyl-Met-Leu-Phe
C21H31N3O5S (437.19843160000005)
n-Formyl-methionyl-leucyl-phenyl-alanine
C21H31N3O5S (437.19843160000005)
Neoline
A diterpene alkaloid with formula C24H39NO6 that is isolated from several Aconitum species. Neoline is a natural product found in Aconitum variegatum, Aconitum karakolicum, and other organisms with data available. Neoline,?the active ingredient of processed aconite root (PA), alleviated oxaliplatin-induced peripheral neuropathy in mice. Neoline can be used as a marker compound to determine the quality of the PA products for the treatment of neuropathic pain[1]. Neoline,?the active ingredient of processed aconite root (PA), alleviated oxaliplatin-induced peripheral neuropathy in mice. Neoline can be used as a marker compound to determine the quality of the PA products for the treatment of neuropathic pain[1].
Foresticine
A diterpene alkaloid with formula C24H39NO6, originally isolated from Aconitum forrestii.
Phosphatidylethanolamine lyso alkenyl 16:0
C21H44NO6P (437.29060940000005)
([1,2]Ra,32S)-16-hydroxy-24,5-dimethoxy-(32rH,34tH,39ac)-3-octahydro-4-oxa-1(1,3),2(1,2)-dibenzena-3(4,2)-quinolizina-cycloheptaphan-5-one|2-hydroxy-4,5-dimethoxy-13,14-dihydro-(10alpha)-lythran-12-one|Decamin|Decamine|dihydrovertine
17,18-Didehydro(Z-)-Leukotriene E4
C23H35NO5S (437.2235820000001)
L-Isoleucyl-L-amiclenomycyl-L-glutamine
C21H35N5O5 (437.26380600000005)
N1,N5-di-(E)-coumaroyl-spermidine|N1,N5-Di-4-coumaroylspermidien
C25H31N3O4 (437.23144460000003)
6alpha-hydroxydinorerythrophlamide
C23H35NO7 (437.24134000000004)
(S)-4-(4-hydroxyphenyl)-9-[(2Z)-1-oxo-3-(4-hydroxyphenyl)-2-propen-1-yl]-1,5,9-triazacyclotridecan-2-one|meefarnine A
C25H31N3O4 (437.23144460000003)
(+)-Lunaridine|(15aR)-(15ar,19acC17)-15a,6,8,9-tetrahydro-5,10,14-triaza-1(2,9a)-dibenzofurana-cycloheptadecaphane-2t,16t-diene-17,4,15-trione|Lunaridin|lunaridine
C25H31N3O4 (437.23144460000003)
4-O-beta-D-glucopyranosyl-3-deoxy-alpha-1-C-(8-hydroxyloctyl)-1-deoxynojirimycin
20-ethyl-14alpha,16xi-dimethoxy-4-methoxymethyl-aconitane-1alpha,7,8-triol|Umbrosin|umbrosine
(1alpha,6beta,14alpha,16beta)-1,19-epoxy-20-ethyl-4-(hydroxymethyl)-6,16-dimethoxyaconitane-7,8,14-triol|1-O,19-didehydrotakaosamine
C23H35NO7 (437.24134000000004)
TRIPARANOL
C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents D009676 - Noxae > D000963 - Antimetabolites
Subcusine
Origin: Plant; SubCategory_DNP: Terpenoid alkaloids, Diterpene alkaloid, Aconitum alkaloid
7-Hydroxyestradiol-3,4-quinone-guanine
C23H27N5O4 (437.20629420000006)
Ala Gly Lys Tyr
Ala Gly Tyr Lys
Ala His Asn Pro
Ala His Pro Asn
Ala Lys Gly Tyr
Ala Lys Tyr Gly
Ala Asn His Pro
Ala Asn Pro His
Ala Pro His Asn
Ala Pro Asn His
Ala Tyr Gly Lys
Ala Tyr Lys Gly
Phe Gly Lys Ser
Phe Gly Ser Lys
Phe Lys Gly Ser
Phe Lys Ser Gly
Phe Ser Gly Lys
Phe Ser Lys Gly
Gly Ala Lys Tyr
Gly Ala Tyr Lys
Gly Phe Lys Ser
Gly Phe Ser Lys
Gly His Lys Pro
Gly His Pro Lys
Gly His Pro Gln
Gly His Gln Pro
Gly Lys Ala Tyr
Gly Lys Phe Ser
Gly Lys His Pro
Gly Lys Pro His
Gly Lys Ser Phe
Gly Lys Tyr Ala
Gly Pro His Lys
Gly Pro His Gln
Gly Pro Lys His
Gly Pro Gln His
Gly Gln His Pro
Gly Gln Pro His
Gly Ser Phe Lys
Gly Ser Lys Phe
Gly Tyr Ala Lys
Gly Tyr Lys Ala
His Ala Asn Pro
His Ala Pro Asn
His Gly Lys Pro
His Gly Pro Lys
His Gly Pro Gln
His Gly Gln Pro
His Lys Gly Pro
His Lys Pro Gly
His Asn Ala Pro
His Asn Pro Ala
His Pro Ala Asn
His Pro Gly Lys
His Pro Gly Gln
His Pro Lys Gly
His Pro Asn Ala
His Pro Gln Gly
His Gln Gly Pro
His Gln Pro Gly
Lys Ala Gly Tyr
Lys Ala Tyr Gly
Lys Phe Gly Ser
Lys Phe Ser Gly
Lys Gly Ala Tyr
Lys Gly Phe Ser
Lys Gly His Pro
Lys Gly Pro His
Lys Gly Ser Phe
Lys Gly Tyr Ala
Lys His Gly Pro
Lys His Pro Gly
Lys Pro Gly His
Lys Pro His Gly
Lys Pro Pro Pro
C21H35N5O5 (437.26380600000005)
Lys Ser Phe Gly
Lys Ser Gly Phe
Lys Tyr Ala Gly
Lys Tyr Gly Ala
Asn Ala His Pro
Asn Ala Pro His
Asn His Ala Pro
Asn His Pro Ala
Asn Pro Ala His
Asn Pro His Ala
Pro Ala His Asn
Pro Ala Asn His
Pro Gly His Lys
Pro Gly His Gln
Pro Gly Lys His
Pro Gly Gln His
Pro His Ala Asn
Pro His Gly Lys
Pro His Gly Gln
Pro His Lys Gly
Pro His Asn Ala
Pro His Gln Gly
Pro Lys Gly His
Pro Lys His Gly
Pro Lys Pro Pro
C21H35N5O5 (437.26380600000005)
Pro Asn Ala His
Pro Asn His Ala
Pro Pro Lys Pro
C21H35N5O5 (437.26380600000005)
Pro Pro Pro Lys
C21H35N5O5 (437.26380600000005)
Pro Pro Pro Gln
Pro Pro Gln Pro
Pro Gln Gly His
Pro Gln His Gly
Pro Gln Pro Pro
Gln Gly His Pro
Gln Gly Pro His
Gln His Gly Pro
Gln His Pro Gly
Gln Pro Gly His
Gln Pro His Gly
Gln Pro Pro Pro
Ser Phe Gly Lys
Ser Phe Lys Gly
Ser Gly Phe Lys
Ser Gly Lys Phe
Ser Lys Phe Gly
Ser Lys Gly Phe
Tyr Ala Gly Lys
Tyr Ala Lys Gly
Tyr Gly Ala Lys
Tyr Gly Lys Ala
Tyr Lys Ala Gly
Tyr Lys Gly Ala
Platelet-activating factor
C20H40NO7P (437.2542260000001)
Lagerstremine
N1,N10-Dicoumaroylspermidine
C25H31N3O4 (437.23144460000003)
LysoPE O-16:1
C21H44NO6P (437.29060940000005)
Alpertine
C25H31N3O4 (437.23144460000003)
C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent
9,9-Dimethyl-N-[1,1:4,1-terphenyl]-4-yl-9H-fluoren-2-amine
tert-Butyl ((2S,4S)-4-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-methyl-1-oxohexan-2-yl)carbamate
N-([1,1:3,1-terphenyl]-5-yl)-9,9-dimethyl-9H-fluoren-2-amine
2-PHENYLCARBAMOYL-1,4-NAPHTHOQUINONE-4-(4-DIETHYLAMINO-2-METHYLPHENYL)IMINE
1,9-Phenanthridinediol, 5,6,6a,7,8,9,10,10a-octahydro-6-methyl-3-(1-methyl-4-phenylbutoxy)-, 1-acetate
C27H35NO4 (437.25659500000006)
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D005765 - Gastrointestinal Agents > D000932 - Antiemetics
Amperozide hydrochloride
C23H30ClF2N3O (437.20453440000006)
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist
Cyclazosin
C23H27N5O4 (437.20629420000006)
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
6-[4-(Diethylamino)phenyl]-9-phenyl-5,6,8,9,10,11-hexahydrobenzo[b][1,4]benzodiazepin-7-one
(21S)-1Aza-4,4-dimethyl-6,19-dioxa-2,3,7,20-tetraoxobicyclo[19.4.0] pentacosane
For-Met-Leu-Phe-OH
C21H31N3O5S (437.19843160000005)
N-Formyl-Met-Leu-Phe (fMLP; N-Formyl-MLF) is a chemotactic peptide and a specific ligand of N-formyl peptide receptor (FPR). N-Formyl-Met-Leu-Ph is reported to inhibit TNF-alpha secretion.
3-[(1,2,4a,5-tetramethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl)methyl]-4-hydroxy-5-[2-(1H-imidazol-5-yl)ethylamino]cyclohexa-3,5-diene-1,2-dione
(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-3-[[(2S)-2-azaniumyl-5-[diaminomethylidene(methyl)azaniumyl]-3-methylpentanoyl]amino]-3,6-dihydro-2H-pyran-2-carboxylate
[(4S)-4-amino-5-[[(2S,3S,6R)-6-(4-amino-2-oxopyrimidin-1-yl)-2-carboxy-3,6-dihydro-2H-pyran-3-yl]amino]-3-methyl-5-oxopentyl]-(diaminomethylidene)-methylazanium
2-(N-[2-[(2-formamido-4-methylsulfanylbutanoyl)amino]-4-methylpentanoyl]anilino)propanoic acid
C21H31N3O5S (437.19843160000005)
[4-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-2,3,4a,5,6,7,8,8a-octahydroquinoxalin-1-yl]-(2-furanyl)methanone
C23H27N5O4 (437.20629420000006)
(3R,3As,7R,7aS)-2-benzyl-3-[4-fluoro-3-[(E)-2-phenylethenyl]phenyl]-7-methyl-3a,6,7,7a-tetrahydro-3H-isoindol-1-one
benzyl N-[(1S)-1-[[4-(dimethylamino)-1-(2-fluoroacetyl)-4-oxo-butyl]carbamoyl]-2-methyl-butyl]carbamate
20-Ethyl-1alpha,16beta-dimethoxy-4-(methoxymethyl)aconitane-6alpha,8,14alpha-triol
1-[(3aR,4S,9bR)-4-(hydroxymethyl)-8-(4-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
C25H31N3O4 (437.23144460000003)
1-[(3aS,4R,9bS)-4-(hydroxymethyl)-8-(4-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
C25H31N3O4 (437.23144460000003)
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-N-(2-piperidin-1-ylethyl)-7-pyridin-3-yl-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-1-methyl-2-[oxo(1-piperidinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C25H31N3O4 (437.23144460000003)
(1R,9S,10S,11S)-12-(cyclopropylmethyl)-N-ethyl-10-(hydroxymethyl)-5-(4-methoxyphenyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C25H31N3O4 (437.23144460000003)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-N-[2-(1-piperidinyl)ethyl]-7-(3-pyridinyl)-1,2,3,3a,4,9b-hexahydropyrrolo[2,3-a]indolizine-2-carboxamide
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-7-(2-methoxyphenyl)-1-methyl-2-(piperidine-1-carbonyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
C25H31N3O4 (437.23144460000003)
(1S,9R,10R,11R)-12-(cyclopropylmethyl)-N-ethyl-10-(hydroxymethyl)-5-(4-methoxyphenyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C25H31N3O4 (437.23144460000003)
N-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
C21H31N3O5S (437.19843160000005)
N-[[(2S,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
C21H31N3O5S (437.19843160000005)
N-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
C21H31N3O5S (437.19843160000005)
N-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
C21H31N3O5S (437.19843160000005)
N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzamide
C25H31N3O4 (437.23144460000003)
N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzamide
C25H31N3O4 (437.23144460000003)
N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzamide
C25H31N3O4 (437.23144460000003)
N-[(2R,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide
C22H32ClN3O4 (437.20812220000005)
N-[(2R,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide
C22H32ClN3O4 (437.20812220000005)
N-[(2S,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide
C22H32ClN3O4 (437.20812220000005)
(2R,3R,3aS,9bS)-7-(1-cyclopentenyl)-1-(cyclopropylmethyl)-3-(hydroxymethyl)-2-[oxo(1-piperidinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
N-[[(2S,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
C21H31N3O5S (437.19843160000005)
N-[[(2R,3R)-8-(1-cyclopentenyl)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
C21H31N3O5S (437.19843160000005)
N-[[(2R,3S)-8-(1-cyclopentenyl)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylmethanesulfonamide
C21H31N3O5S (437.19843160000005)
N-[(2R,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzamide
C25H31N3O4 (437.23144460000003)
N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzamide
C25H31N3O4 (437.23144460000003)
N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-oxo-2-(4-phenyl-1-piperazinyl)ethyl]-3-oxanyl]benzamide
C25H31N3O4 (437.23144460000003)
N-[(2S,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide
C22H32ClN3O4 (437.20812220000005)
N-[(2S,3R,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide
C22H32ClN3O4 (437.20812220000005)
N-[(2S,3S,6R)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide
C22H32ClN3O4 (437.20812220000005)
N-[(2R,3S,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide
C22H32ClN3O4 (437.20812220000005)
N-[(2R,3R,6S)-6-[2-[[(4-chloroanilino)-oxomethyl]amino]ethyl]-2-(hydroxymethyl)-3-oxanyl]cyclohexanecarboxamide
C22H32ClN3O4 (437.20812220000005)
(2S,3S,3aR,9bR)-7-(1-cyclopentenyl)-1-(cyclopropylmethyl)-3-(hydroxymethyl)-2-[oxo(1-piperidinyl)methyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizin-6-one
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-N-[(4-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-[(3aR,4R,9bR)-4-(hydroxymethyl)-8-(4-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
C25H31N3O4 (437.23144460000003)
1-[(3aS,4S,9bS)-4-(hydroxymethyl)-8-(4-methoxyphenyl)-2,3,3a,4,5,9b-hexahydropyrrolo[3,2-c]quinolin-1-yl]-2-(4-morpholinyl)ethanone
C25H31N3O4 (437.23144460000003)
(2-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-2-methyl-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
(3-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
[(1S)-2-[(4-fluorophenyl)methyl]-7-methoxy-1,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]methanol
C26H32FN3O2 (437.24784239999997)
(4-fluorophenyl)-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
(4-fluorophenyl)-[(1R)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-spiro[2,3-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]methanone
Phosphatidylethanolamine lyso alkenyl 16
C21H44NO6P (437.29060940000005)
1-ethyl-2-[7-(1-ethyl-3,3-dimethyl-1,3-dihydro-2H-indol-2-ylidene)hepta-1,3,5-trien-1-yl]-3,3-dimethyl-3H-indolium
2-aminoethyl (2R)-3-{[(1E)-hexadec-1-en-1-yl]oxy}-2-hydroxypropyl hydrogen phosphate
C21H44NO6P (437.29060940000005)
2-azaniumylethyl (2R)-3-{[(1E)-hexadec-1-en-1-yl]oxy}-2-hydroxypropyl phosphate
C21H44NO6P (437.29060940000005)
methyl (2S)-2-[6-(2-ethylphenyl)-4,7-dimethyl-1,3-dioxopurino[7,8-a]imidazol-2-yl]-3-methylbutanoate
C23H27N5O4 (437.20629420000006)
(1S,4S,5S,6S,8R,9R,10R,13S,16S,18S)-11-ethyl-6,18-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.12,5.01,10.03,8.013,17]nonadecane-4,8,16-triol
2-aminoethyl [3-[(Z)-hexadec-9-enoxy]-2-hydroxypropyl] hydrogen phosphate
C21H44NO6P (437.29060940000005)
[2-hydroxy-3-[(Z)-tridec-9-enoxy]propyl] 2-(trimethylazaniumyl)ethyl phosphate
C21H44NO6P (437.29060940000005)
[3-[2-aminoethoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] (Z)-pentadec-9-enoate
C20H40NO7P (437.2542260000001)
[1-[2-aminoethoxy(hydroxy)phosphoryl]oxy-3-[(Z)-tridec-9-enoxy]propan-2-yl] acetate
C20H40NO7P (437.2542260000001)
2-[[(E)-2-acetamido-3-hydroxytridec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H42N2O6P+ (437.27803420000004)
2-[hydroxy-[(E)-3-hydroxy-2-(pentanoylamino)dec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C20H42N2O6P+ (437.27803420000004)
2-[hydroxy-[(E)-3-hydroxy-2-(propanoylamino)dodec-4-enoxy]phosphoryl]oxyethyl-trimethylazanium
C20H42N2O6P+ (437.27803420000004)
2-[[(E)-2-(hexanoylamino)-3-hydroxynon-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H42N2O6P+ (437.27803420000004)
2-[[(E)-2-(heptanoylamino)-3-hydroxyoct-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H42N2O6P+ (437.27803420000004)
2-[[(E)-2-(butanoylamino)-3-hydroxyundec-4-enoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium
C20H42N2O6P+ (437.27803420000004)
N1,N10-Bis(p-coumaroyl)spermidine
C25H31N3O4 (437.23144460000003)
A secondary amino compound that is spermidine in which each of the primary amino groups has been mono-acylated by formal condensation with trans-coumaric acid.
2-chloro-1-[(2S,3S,5S,10S,13S)-3-hydroxy-10,13-dimethyl-2-morpholin-4-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
C25H40ClNO3 (437.26965600000005)
1-(1Z-hexadecenyl)-sn-glycero-3-phosphoethanolamine
C21H44NO6P (437.29060940000005)
N-Formylmethionyl-leucylphenylalanine
C21H31N3O5S (437.19843160000005)
Bullatine B
Neoline,?the active ingredient of processed aconite root (PA), alleviated oxaliplatin-induced peripheral neuropathy in mice. Neoline can be used as a marker compound to determine the quality of the PA products for the treatment of neuropathic pain[1]. Neoline,?the active ingredient of processed aconite root (PA), alleviated oxaliplatin-induced peripheral neuropathy in mice. Neoline can be used as a marker compound to determine the quality of the PA products for the treatment of neuropathic pain[1].
1-(9E-decenyl)-2-acetyl-sn-glycero-3-phosphocholine
C20H40NO7P (437.2542260000001)
1-(9Z-pentadecenoyl)-glycero-3-phosphoethanolamine
C20H40NO7P (437.2542260000001)
1-[(E)-hexadec-1-enyl]-sn-glycero-3-phosphoethanolamine
C21H44NO6P (437.29060940000005)
1-(alk-1-enyl)-sn-glycero-3-phosphoethanolamine in which the alk-1-enyl group is specified as (E)-hexadec-1-enyl.
1-[(E)-hexadec-1-enyl]-sn-glycero-3-phosphoethanolamine zwitterion
C21H44NO6P (437.29060940000005)
1-(alk-1-enyl)-sn-glycero-3-phosphoethanolamine zwitterion in which the alk-1-enyl group is specified as (E)-hexadec-1-enyl.
PE(14:1)
C19H36NO8P (437.21784260000004)
Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved
NA-Dopamine 20:5(5Z,8Z,11Z,14Z,17Z)
C28H39NO3 (437.29297840000004)
NA-Taurine 22:5(7Z,10Z,13Z,16Z,19Z)
C24H39NO4S (437.25996540000006)
(1s,2s,4s,6s,9s,10s,11r,13s,14s,15s,16r,17r,18r,19s)-8-ethyl-11,13,19-trimethoxy-5-oxa-8-azaheptacyclo[8.7.2.1¹⁴,¹⁷.0¹,⁹.0⁴,⁶.0⁶,¹⁸.0¹¹,¹⁶]icosane-2,10,15-triol
C23H35NO7 (437.24134000000004)
7-(2-hydroxypropan-2-yl)-1,2,10-trimethyl-6-oxa-23-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁶,²⁴.0¹⁷,²²]tetracosa-16(24),17,19,21-tetraen-9-ol
C28H39NO3 (437.29297840000004)
11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-2,4,8-triol
(1s,2e,16e,23r)-4,15-dihydroxy-22-oxa-5,9,14-triazatetracyclo[16.9.2.0¹,²³.0²¹,²⁸]nonacosa-2,4,14,16,18,20,28-heptaen-25-one
C25H31N3O4 (437.23144460000003)
4,15-dihydroxy-22-oxa-5,9,14-triazatetracyclo[16.9.2.0¹,²³.0²¹,²⁸]nonacosa-2,4,14,16,18,20,28-heptaen-25-one
C25H31N3O4 (437.23144460000003)
11-ethyl-6-methoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-14-ene-4,8,9,16,18-pentol
C23H35NO7 (437.24134000000004)
methyl 2,9-dihydroxy-7-{[(2-hydroxyethyl)(methyl)carbamoyl]methylidene}-1,4a,8-trimethyl-decahydro-2h-phenanthrene-1-carboxylate
(1s,2r,3r,4s,5s,6s,8r,9r,10s,13s,16s,17r)-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-4,8,9-triol
11-ethyl-13-(hydroxymethyl)-4,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
(1s,2r,3s,4s,5r,6r,8r,9r,10s,13r,16r,17s)-11-ethyl-6,16-dimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-2,4,8-triol
(1s,2r,3r,4s,5s,8r,9s,10s,13s,16s,17r,18s)-11-ethyl-13-(hydroxymethyl)-4,16,18-trimethoxy-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecane-8,9-diol
2-[7,9-dihydroxy-8-(methoxycarbonyl)-1,4b,8-trimethyl-10-oxo-decahydrophenanthren-2-ylidene]-n-(2-hydroxyethyl)ethanimidic acid
C23H35NO7 (437.24134000000004)